Altman Advisors, Inc. Novartis Ag Transaction History
Altman Advisors, Inc.
- $224 Million
- Q3 2024
A detailed history of Altman Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Altman Advisors, Inc. holds 15,656 shares of NVS stock, worth $1.52 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
15,656
Previous 15,566
0.58%
Holding current value
$1.52 Million
Previous $1.66 Million
8.63%
% of portfolio
0.8%
Previous 0.95%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.19 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.17 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$788 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$680 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$562 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $209B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...